NANOSTRING TECHNOLOGIES INC. (Bruker Spatial Biology Inc.)
Company Snapshot
Company Overview
NanoString Technologies Inc. is developing and marketing technologies for targeted detection of biological markers. NanoString’s platform technology is nCounter, which is very sensitive and detects a wide range of markers including DNA, RNA and proteins. nCounter is able to count a single biomarker and can detect up to 800 unique biomarkers from the same sample. The nCounter instrument uses proprietary consumables and is automated.
Newer technology platforms that the company is developing include hybridization-based sequencing (Hyb & Seq) and Digital Spatial Profiling (DSP).
The Hyb & Seq platform has been shown to be useful for liquid biopsy downstream analysis of cfDNA. For this application, the advantage of Hyb & Seq is that it can directly capture and analyze cfDNA without amplification or library construction. This gives a high yield of cfDNA with minimal contamination from cellular genomic DNA.
In December 2019, NanoString licensed its nCounter platform to Veracyte for diagnostic use. This deal enables NanoString to focus on being a research platform provider, including its nCounter gene expression profiling instruments and increasing adoption of its GeoMx Digital Spatial Profiler platform. Growing the customer base for the GeoMx platform is the company’s highest priority.
In October 2023, ASTAR’s Genome Institute of Singapore (GIS), NanoString Technologies Inc. and Next Level Genomics (NLG) announced the creation of the SpACE-Dx lab in Singapore. This joint laboratory, situated at ASTAR’s GIS facility, will specialize in applying spatial biology to identify biomarkers for predicting disease progression and treatment response, particularly in cancer. The lab will leverage spatial multiomic technologies to advance research in complex diseases, promoting collaboration and accelerating spatial genomics advancements within the local research community.
NANOSTRING TECHNOLOGIES INC. (Bruker Spatial Biology Inc.) In Reports
NANOSTRING TECHNOLOGIES INC. (Bruker Spatial Biology Inc.) In News
Company's Business Segments
- Product : This segment inclues Instruments, Consumables.
- Service : We Develop, Deliver, Manage Cloud-based Services.
Applications/End User Industries
- Genomics
- Proteomics
- Clinical Research
- Pharmaceuticals
- Healthcare
- Immunology
- Neurology
- Genes
- Biopharmaceutical
- Laboratories
- Spatial Biology Platforms
- Human Genomes
- Mutations
- Human Clinical Trials
- Life Science Researchers